ClinicalTrials.gg
Sign In

Plaque, Atherosclerotic clinical trials

The registry lists 105 studies for Plaque, Atherosclerotic across more than 10 countries. 27 are recruiting or about to start. 30 of them are mainly about Plaque, Atherosclerotic (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10.

Get an email when these change. Save the Plaque, Atherosclerotic studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
40
Status unknown
19
Recruiting
16
Active, not recruiting
11
Not yet recruiting
8
Terminated
4

Phase

Phase 4
17
Phase 3
12
Phase 1
5
Phase 2
4

Where

United States
19
Korea, Republic of
14
China
13
France
10
Netherlands
9
Canada
8

Who runs them

Cardio Med Medical Center (4) · Radboud University Medical Center (3) · Second Affiliated Hospital, School of Medicine, Zhejiang University (3) · Novartis Pharmaceuticals (3) · Assistance Publique Hopitaux De Marseille (2) · Seoul National University Hospital (2) · Massachusetts General Hospital (2) · GlaxoSmithKline (2)

What is being tested here

Drugs under test in Plaque, Atherosclerotic studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Recaticimab202
Inclisiran124
Rosuvastatin104
Alirocumab122
Evolocumab101
Eicosapentaenoic acid ethyl ester111
Fish Oils101
Metformin101
Aspirin101
Niacin012

Drug classes tested here Statins 2 open · PCSK9 inhibitors 2 open

Coming up

5phase 3 studies under way
12studies finish main data collection within a year2 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 16 Plaque, Atherosclerotic studies recruiting now, 7 (44%) set no upper age limit and 4 (25%) stop at 75 or younger. 0 (0%) take children under 18. 1 (6%) are for women only and 0 (0%) for men only; 1 (6%) take healthy volunteers.

Recruiting studies that take each age, of 16
AgeWomenMen
100 (0%)0 (0%)
1811 (69%)11 (69%)
3012 (75%)11 (69%)
4014 (88%)13 (81%)
5015 (94%)15 (94%)
6515 (94%)15 (94%)
7514 (88%)14 (88%)
858 (50%)8 (50%)

Across all 105 studies, recruiting or not: 17% stop at 75 or younger and 4% at 65; 7% take children; 2% are for women only and 1% for men only; 10% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Plaque, Atherosclerotic studies take

Of 31 observational studies under Plaque, Atherosclerotic, half reached primary completion within 36 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Observational36 mo22–105 · 31 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 105. Browse all 105 → or search them.